Congenital Heart Disease Screening Highlights AJPB Week in Review

Top articles of the week from The American Journal of Pharmacy Benefits.

5. Link Between Diabetes, Cardiovascular Disease Guide Current Clinical Trials

Patients with diabetes are significantly more likely to develop cardiovascular disease than nondiabetic patients. Read more.4. Novel ADHD Digital Therapy Shows Promise

Children with ADHD treated with AKL-T01 showed a significant positive improvement in attention. Read more.

3. Once-Weekly Semaglutide Approved for Type 2 Diabetes

The FDA issued approval to semaglutide injection (Ozempic) for type 2 diabetes. Read more.2. Blood-Brain Barrier May Present Treatment Target in Multiple Sclerosis

Targeting specific transportation system across the damaged blood-brain barrier could halt MS disease progression. Read more.1. Congenital Heart Disease Screening Prevents Infant Deaths

Pulse oximetry found to reduce infant death from congenital heart disease by 33%. Read more.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.